Orthofix Medical is a medical device and biologics company. Co.'s Global Spine segment provides implantable medical devices, biologics, and other regenerative solutions. This segment's product categories include: Bone Growth Therapies, which manufactures, distributes, and provides support services for bone growth stimulation devices; Spinal Implants, which designs, develops and markets a portfolio of motion preservation and fixation implant products; and Biologics, which provides a portfolio of regenerative products and tissue forms. Co.'s Global Extremities segment provides products and solutions that allow physicians to treat a variety of orthopedic conditions unrelated to the spine. The OFIX stock yearly return is shown above.
The yearly return on the OFIX stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2015 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the OFIX annual return calculation with any dividends reinvested as applicable (on ex-dates).
|